Can we influence the epidemiology of dementia? Perspectives from population-based studies

被引:12
作者
Birdi, Ratika [1 ]
Stephan, Blossom Christa Maree [1 ]
Robinson, Louise [1 ]
Davis, Daniel [2 ,3 ]
机构
[1] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] UCL, MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England
[3] St Marys Hosp, Geriatr Med, London WC1B 5JU, England
基金
英国医学研究理事会;
关键词
MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; PREVALENCE; METAANALYSIS; ASSOCIATION; RISK;
D O I
10.1136/postgradmedj-2015-133244
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The worldwide prevalence of dementia is predicted to rise significantly in the next three decades. However, these projections have not taken into account the role of modifiable risk factors and whether any prevention strategies might influence the predicted trend. Attempts at pharmacological disease modification have largely been disappointing, and the difficulties in conducting dementia trials are reviewed here. In contrast, recent population studies in high-income countries suggest that the epidemiology may be changing with a possible decline in incident dementia, or even a reduction in age-specific prevalence. Therefore, efforts to develop public health interventions may prove to be the more successful approach to addressing dementia at a societal level.
引用
收藏
页码:651 / 654
页数:4
相关论文
共 26 条
[1]   The projected effect of risk factor reduction on Alzheimer's disease prevalence [J].
Barnes, Deborah E. ;
Yaffe, Kristine .
LANCET NEUROLOGY, 2011, 10 (09) :819-828
[2]   Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis [J].
Beydoun, May A. ;
Beydoun, Hind A. ;
Gamaldo, Alyssa A. ;
Teel, Alison ;
Zonderman, Alan B. ;
Wang, Youfa .
BMC PUBLIC HEALTH, 2014, 14
[3]   A population perspective on the IWG-2 research diagnostic criteria for Alzheimer's disease Comment [J].
Brayne, Carol .
LANCET NEUROLOGY, 2014, 13 (06) :532-534
[4]   Making Alzheimer's and dementia research fit for populations [J].
Brayne, Carol ;
Davis, Daniel .
LANCET, 2012, 380 (9851) :1441-1443
[5]   Dementia - Epidemiological considerations, nomenclature, and a tacit consensus definition [J].
Breitner, John C. S. .
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2006, 19 (03) :129-136
[6]   Alzheimer's disease drug-development pipeline: few candidates, frequent failures [J].
Cummings, Jeffrey L. ;
Morstorf, Travis ;
Zhong, Kate .
ALZHEIMERS RESEARCH & THERAPY, 2014, 6 (04)
[7]   International Work Group Criteria for the Diagnosis of Alzheimer Disease [J].
Cummings, Jeffrey L. ;
Dubois, Bruno ;
Molinuevo, Jose L. ;
Scheltens, Philip .
MEDICAL CLINICS OF NORTH AMERICA, 2013, 97 (03) :363-+
[8]   Modifiable Lifestyle Factors in Dementia: A Systematic Review of Longitudinal Observational Cohort Studies [J].
Di Marco, Luigi Yuri ;
Marzo, Alberto ;
Munoz-Ruiz, Miguel ;
Ikram, M. Arfan ;
Kivipelto, Miia ;
Ruefenacht, Daniel ;
Venneri, Annalena ;
Soininen, Hilkka ;
Wanke, Isabel ;
Ventikos, Yiannis A. ;
Frangi, Alejandro F. .
JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (01) :119-135
[9]   Midlife and Late-Life Obesity and the Risk of Dementia Cardiovascular Health Study [J].
Fitzpatrick, Annette L. ;
Kuller, Lewis H. ;
Lopez, Oscar L. ;
Diehr, Paula ;
O'Meara, Ellen S. ;
Longstreth, W. T., Jr. ;
Luchsinger, Jose A. .
ARCHIVES OF NEUROLOGY, 2009, 66 (03) :336-342
[10]   Clinical development success rates for investigational drugs [J].
Hay, Michael ;
Thomas, David W. ;
Craighead, John L. ;
Economides, Celia ;
Rosenthal, Jesse .
NATURE BIOTECHNOLOGY, 2014, 32 (01) :40-51